Literature DB >> 20464529

Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive care.

Christopher J Taylor1, Fergus Robertson, David Brealey, Frankie O'shea, Tina Stephen, Stefan Brew, Joan P Grieve, Martin Smith, Ian Appleby.   

Abstract

BACKGROUND: Patients with poor grade (World Federation of Neurosurgeons (WFNS) Grades 4 and 5) subarachnoid hemorrhage (SAH) were historically considered to have a poor neurological outcome and therefore not traditionally offered aggressive treatment. In recent years there has been increasing evidence that early aggressive treatment of this patient group can result in a good outcome. Aim of this study is to identify the outcome of patients with WFNS Grade-4 and -5 SAH treated acutely with endovascular detachable coil embolization (DCE) and aggressive neurocritical care within our institution.
METHODS: We retrospectively reviewed the records of patients with SAH WFNS Grades 4 and 5 treated with DCE within 7 days of admission between 1st January 2004 and 1st January 2008. Data collected included age, sex, grade SAH, position/number of Aneurysms, coiling complications, time spent on the neurosurgical critical care unit (NCCU), and 6-month outcome assessed by Glasgow outcome scale (GOS). GOS was dichotomized into good outcome (good recovery/moderate disability) and poor outcome (severe disability, vegetative, dead).
RESULTS: A total of 193 acute SAH patients were admitted and treated within this time period, of these, 47 patients were classified as poor grade and included: 70% were female and 30% were male. The mean age was 56 years (33-88 years range). A total of 56 aneurysms were noted at angiography, 52 aneurysms were coiled. Complications of SAH Vasospasm was noted in 18 patients (38%), cerebral infarction in 13 patients (28%), seizures in 7 patients (15%), hydrocephalus in 25 patients (53%). Complications of DCE occurred in 2 patients (4% of total) these were an aneurysmal rupture and a peri-procedure thrombosis. Incomplete coiling occurred in another 5 patients (10.6% of total) due to technical difficulties. The median length of stay on the NCCU was 12 days (1-52 days range). Of the 47 poor grade patients coiled, 25 (53%) had a good outcome (good recovery/moderate disability) and 22 (47%) had a poor outcome (severe disability, vegetative, dead) by the time of the 6-month follow-up.
CONCLUSION: Potentially, more than half the patients with WFNS Grade-4 and -5 SAH who are treated aggressively with coil embolization in association with supportive neurocritical care can achieve a good quality neurological outcome. However, it should be anticipated that these patients will spend a significant period of time in neurocritical care.

Entities:  

Mesh:

Year:  2011        PMID: 20464529     DOI: 10.1007/s12028-010-9377-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  27 in total

1.  Early endovascular treatment of ruptured cerebral aneurysms in patients in very poor neurological condition.

Authors:  Johannes van Loon; Yannic Waerzeggers; Guido Wilms; Frank Van Calenbergh; Jan Goffin; Christian Plets
Journal:  Neurosurgery       Date:  2002-03       Impact factor: 4.654

2.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

3.  Rupture of intracranial aneurysms during treatment with Guglielmi detachable coils: incidence, outcome, and risk factors.

Authors:  M Sluzewski; J A Bosch; W J van Rooij; P C Nijssen; D Wijnalda
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

4.  Acute endovascular treatment of ruptured aneurysms in poor-grade patients.

Authors:  M Bergui; G B Bradac
Journal:  Neuroradiology       Date:  2003-12-20       Impact factor: 2.804

Review 5.  Intensive care management of patients with subarachnoid haemorrhage.

Authors:  Martin Smith
Journal:  Curr Opin Anaesthesiol       Date:  2007-10       Impact factor: 2.706

6.  Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm.

Authors:  Martin A Seule; Carl Muroi; Susanne Mink; Yasuhiro Yonekawa; Emanuela Keller
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

7.  Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  A Hijdra; J van Gijn; N J Nagelkerke; M Vermeulen; H van Crevel
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

8.  Early management of aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.

Authors:  H P Adams; N F Kassell; J C Torner; D W Nibbelink; A L Sahs
Journal:  J Neurosurg       Date:  1981-02       Impact factor: 5.115

9.  Predictors of 1-year outcome after coiling for poor-grade subarachnoid aneurysmal hemorrhage.

Authors:  Ana R Pereira; Paola Sanchez-Peña; Alessandra Biondi; Nader Sourour; Anne L Boch; Chantal Colonne; Lise Lejean; Lamine Abdennour; Louis Puybasset
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

10.  Overall results in 304 consecutive patients with acute spontaneous subarachnoid hemorrhage.

Authors:  C Testa; A Andreoli; A Arista; P Limoni; F Tognetti
Journal:  Surg Neurol       Date:  1985-10
View more
  15 in total

1.  Application of actuator-driven pulsed water jet in aneurysmal subarachnoid hemorrhage surgery: its effectiveness for dissection around ruptured aneurysmal walls and subarachnoid clot removal.

Authors:  Hidenori Endo; Toshiki Endo; Atsuhiro Nakagawa; Miki Fujimura; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-12-22       Impact factor: 3.042

2.  Outcome of poor-grade subarachnoid hemorrhage as determined by biomarkers of glucose cerebral metabolism.

Authors:  Gleicy K Barcelos; Yannick Tholance; Sebastien Grousson; Bernard Renaud; Armand Perret-Liaudet; Frederic Dailler; Luc Zimmer
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

3.  Comparative evaluation of H&H and WFNS grading scales with modified H&H (sans systemic disease): A study on 1000 patients with subarachnoid hemorrhage.

Authors:  Ashish Aggarwal; Sivashanmugam Dhandapani; Kokkula Praneeth; Harsimrat Bir Singh Sodhi; Sudhir Singh Pal; Sachin Gaudihalli; N Khandelwal; Kanchan K Mukherjee; M K Tewari; Sunil Kumar Gupta; S N Mathuriya
Journal:  Neurosurg Rev       Date:  2017-03-15       Impact factor: 3.042

Review 4.  High-volume centers.

Authors:  P Vespa; Michael N Diringer
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

5.  Treatment of poor-grade subarachnoid hemorrhage trial.

Authors:  D Mitra; B Gregson; V Jayakrishnan; A Gholkar; A Vincent; P White; P Mitchell
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-24       Impact factor: 3.825

6.  Milrinone via lumbar subarachnoid catheter for vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Nobutake Sadamasa; Kazumichi Yoshida; Osamu Narumi; Masaki Chin; Sen Yamagata
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

7.  Factors and outcomes associated with ultra-early surgery for poor-grade aneurysmal subarachnoid haemorrhage: a multicentre retrospective analysis.

Authors:  Bing Zhao; Yuanli Zhao; Xianxi Tan; Yong Cao; Jun Wu; Ming Zhong; Shuo Wang
Journal:  BMJ Open       Date:  2015-04-15       Impact factor: 2.692

Review 8.  Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Won-Sang Cho; Jeong Eun Kim; Sukh Que Park; Jun Kyeung Ko; Dae-Won Kim; Jung Cheol Park; Je Young Yeon; Seung Young Chung; Joonho Chung; Sung-Pil Joo; Gyojun Hwang; Deog Young Kim; Won Hyuk Chang; Kyu-Sun Choi; Sung Ho Lee; Seung Hun Sheen; Hyun-Seung Kang; Byung Moon Kim; Hee-Joon Bae; Chang Wan Oh; Hyeon Seon Park
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28

9.  Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society.

Authors:  Katja E Wartenberg; David Y Hwang; Karl Georg Haeusler; Susanne Muehlschlegel; Oliver W Sakowitz; Dominik Madžar; Hajo M Hamer; Alejandro A Rabinstein; David M Greer; J Claude Hemphill; Juergen Meixensberger; Panayiotis N Varelas
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

10.  A Multicenter prospective study of poor-grade aneurysmal subarachnoid hemorrhage (AMPAS): observational registry study.

Authors:  Bing Zhao; Xianxi Tan; Hua Yang; Kuang Zheng; Zequn Li; Ye Xiong; Ming Zhong
Journal:  BMC Neurol       Date:  2014-04-17       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.